中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 合肥物质科学研究院
  3. 中国科学院合肥物质科学研究院
Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma

文献类型：期刊论文

作者Liu, Juan1,2; Liang, Qianmao1,2; Wang, Aoli1,3; Zou, Fengming1,3; Qi, Ziping1,3; Yu, Kailin1; Liu, Qingwang1,3,4,5; Chen, Cheng1,2,3; Liu, Jing1,2,3; Liu, Qingsong1,2,3,4,5,6
刊名SIGNAL TRANSDUCTION AND TARGETED THERAPY
出版日期2020-09-14
卷号5
ISSN号2095-9907
DOI10.1038/s41392-020-00309-1
通讯作者Liu, Jing(jingliu@hmfl.ac.cn) ; Liu, Qingsong(qsliu97@hmfl.ac.cn)
资助项目National Natural Science Foundation of China[81773777] ; National Natural Science Foundation of China[81872748] ; National Natural Science Foundation of China[81803366] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China[2018ZX09711002] ; Natural Science Foundation of Anhui Province[1808085MH268] ; China Postdoctoral Science Foundation[2018T110634] ; China Postdoctoral Science Foundation[2018M630720] ; Frontier Science Key Research Program of CAS[QYZDB-SSW-SLH037] ; Innovative Program of Development Foundation of Hefei Center for Physical Science and Technology[2019HSC-CIP011] ; CASHIPS Director's Fund[BJPY2019A03] ; Key Program of 13th five-year plan of CASHIPS[KP-2017-26] ; Hefei leading talent
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
出版者SPRINGERNATURE
WOS记录号WOS:000572378800003
资助机构National Natural Science Foundation of China ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China ; Natural Science Foundation of Anhui Province ; China Postdoctoral Science Foundation ; Frontier Science Key Research Program of CAS ; Innovative Program of Development Foundation of Hefei Center for Physical Science and Technology ; CASHIPS Director's Fund ; Key Program of 13th five-year plan of CASHIPS ; Hefei leading talent
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/104232]  
专题中国科学院合肥物质科学研究院
通讯作者Liu, Jing; Liu, Qingsong
作者单位1.Chinese Acad Sci, Hefei Inst Phys Sci, Inst Hlth & Med Technol, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China
2.Univ Sci & Technol China, Hefei 230036, Anhui, Peoples R China
3.Chinese Acad Sci, Hefei Canc Hosp, Hefei 230031, Anhui, Peoples R China
4.Precis Med Res Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China
5.Chinese Acad Sci, Hefei Inst Phys Sci, Inst Technol Innovat, Precis Targeted Therapy Discovery Ctr, Hefei 230088, Peoples R China
6.Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China
推荐引用方式
GB/T 7714		 Liu, Juan,Liang, Qianmao,Wang, Aoli,et al. Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2020,5.
APA Liu, Juan.,Liang, Qianmao.,Wang, Aoli.,Zou, Fengming.,Qi, Ziping.,...&Liu, Qingsong.(2020).Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma.SIGNAL TRANSDUCTION AND TARGETED THERAPY,5.
MLA Liu, Juan,et al."Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma".SIGNAL TRANSDUCTION AND TARGETED THERAPY 5(2020).

入库方式： OAI收割

来源：合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。